Angela E. Williams

GlaxoSmithKline, Stockley Park
United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Empowering Medical Affairs Professionals in Their Critical Role in Integrated Evidence Generation Planning.

Empowering Medical Affairs Professionals in Their Critical Role in Integrated Evidence Generation Planning.

Journal: Pharmaceutical medicine

Published: June 28, 2026

Patient and care partner burden in cutaneous T-cell lymphoma using disease-specific measures of symptoms and health-related quality of life.

Patient and care partner burden in cutaneous T-cell lymphoma using disease-specific measures of symptoms and health-related quality of life.

Journal: The British journal of dermatology

Published: November 26, 2025

Psychometric Evaluation of Worst Pruritus Numeric Rating Scale in Adults With Moderate-to-Severe Atopic Dermatitis.

Psychometric Evaluation of Worst Pruritus Numeric Rating Scale in Adults With Moderate-to-Severe Atopic Dermatitis.

Journal: Dermatology and therapy

Published: October 31, 2025

The lived experience of adolescents with X-linked hypophosphataemia treated with burosumab at end of skeletal growth: a mixed-methods analysis.

The lived experience of adolescents with X-linked hypophosphataemia treated with burosumab at end of skeletal growth: a mixed-methods analysis.

Journal: PloS one

Published: September 24, 2025

Adolescents' experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growth.

Adolescents' experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growth.

Journal: Orphanet journal of rare diseases

Published: September 04, 2025

Increased lifelong burden of comorbidities without increased early mortality in hereditary hypophosphatemia: a Danish register study.

Increased lifelong burden of comorbidities without increased early mortality in hereditary hypophosphatemia: a Danish register study.

Journal: JBMR plus

Published: March 18, 2025

Health-related quality of life in French pediatric patients with X-linked hypophosphatemia: real-world data from the International XLH Registry.

Health-related quality of life in French pediatric patients with X-linked hypophosphatemia: real-world data from the International XLH Registry.

Journal: JBMR plus

Published: March 07, 2025

Lymphoedema Development Following a Cancer Diagnosis: An Anonymised Data Linkage Study in Wales, United Kingdom.

Lymphoedema Development Following a Cancer Diagnosis: An Anonymised Data Linkage Study in Wales, United Kingdom.

Journal: International wound journal

Published: November 30, 2024

Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study.

Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study.

Journal: Dermatology and therapy

Published: September 30, 2024

Impact of stopping burosumab treatment at the end of skeletal growth in adolescents with X-linked hypophosphatemia (XLH).

Impact of stopping burosumab treatment at the end of skeletal growth in adolescents with X-linked hypophosphatemia (XLH).

Journal: Bone reports

Published: September 17, 2024

Healthcare Resource Use Associated With Tumor-Induced Osteomalacia: A Literature Review.

Healthcare Resource Use Associated With Tumor-Induced Osteomalacia: A Literature Review.

Journal: The Journal of clinical endocrinology and metabolism

Published: March 21, 2024

Association between work productivity and characteristics of adults with X-linked hypophosphatemia: an analysis of the XLH disease monitoring program.

Association between work productivity and characteristics of adults with X-linked hypophosphatemia: an analysis of the XLH disease monitoring program.

Journal: JBMR plus

Published: February 19, 2024

Showing 1-12 of 41

Last Updated: 09/26/2026